Delivery Order SPE2DB22D2103-SPE2DB24FR9ZP
Award Date
9/19/24
Potential Completion Date
9/20/24
Potential Value
$6.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,672.80 firm-fixed-price contract is for the supply of MYDAYIS CAPS 37.5MG, a prescription medication. The contract has an ultimate completion date of October 10, 2024. Amerisourcebergen, through its Corporate Office division, is a significant provider of pharmaceuticals and medical supplies to the U.S. federal...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,061.84 firm fixed-price contract is for the supply of MYDAYIS ER 12.5 MG CAPSULE 100S, with a completion date of November 22, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,226.81, is for the supply of 4568059545 MYDAYIS ER 12.5 MG CAPSULE 100S, a prescription medication. The contract is a Firm Fixed Price, non-set-aside award with an ultimate completion date of April 29, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $1,730.29 firm fixed-price contract is for the delivery of MYDAYIS ER 50 MG CAPSULE 100S, a prescription medication. The contract has a period of performance through May 8, 2023. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
This federal contract award, with a ceiling value of $2,040.01, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of the pharmaceutical product MYDAYIS CAPS 25MG and is a firm fixed-price delivery order with an ultimate completion date of May 14, 2025. The contract is not set aside for any particular business type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
This federal contract award, valued at $1,598.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of October 30, 2024. The contract covers the supply of MYDAYIS ER 50 MG CAPSULE 100S, a pharmaceutical product, to support military healthcare programs. Amerisourcebergen holds a significant...
This federal contract award, valued at $5,064.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of MYDAYIS ER 50 MG CAPSULE 100S, a pharmaceutical product. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The company holds...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, provides for the delivery of MYDAYIS ER 25 MG CAPSULE 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,087.34 firm fixed price delivery order has a completion date of July 31, 2024. The contract does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous Indefinite Delivery Contracts (IDCs) by the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,324.20 fixed-price delivery order is for the supply of the medication MYDAYIS ER 12.5 MG CAPSULE 100S, with a period of performance through March 2025. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a $1,087.34 Firm Fixed Price Delivery Order placed by the Defense Logistics Agency (DLA). The contract covers the provision of MYDAYIS ER 25 MG CAPSULE 100S, a pharmaceutical product, with a period of performance through October 28, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...